Drug Profile
Malaria vaccine - Protein Sciences
Latest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Protein Sciences Corporation
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 28 Aug 2017 Protein Sciences Corporation has been acquired by Sanofi
- 13 Mar 1999 New profile, split from generic Malaria Vaccine profile
- 01 Aug 1993 Discontinued-I for Malaria in USA (Unknown route)